GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » 5-Year Yield-on-Cost %
中文

Lonza Group (Lonza Group) 5-Year Yield-on-Cost % : 0.85 (As of Apr. 24, 2024)


View and export this data going back to 2008. Start your Free Trial

Lonza Group 5-Year Yield-on-Cost % Definition

Lonza Group's yield on cost for the quarter that ended in Dec. 2023 was 0.85.


The historical rank and industry rank for Lonza Group's 5-Year Yield-on-Cost % or its related term are showing as below:

LZAGY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.44   Med: 1.11   Max: 4.09
Current: 0.85

During the past 13 years, Lonza Group's highest Yield on Cost was 4.09. The lowest was 0.44. And the median was 1.11.


LZAGY's 5-Year Yield-on-Cost % is ranked worse than
77.03% of 74 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.405 vs LZAGY: 0.85

Competitive Comparison of Lonza Group's 5-Year Yield-on-Cost %

For the Diagnostics & Research subindustry, Lonza Group's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lonza Group 5-Year Yield-on-Cost % Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Lonza Group's 5-Year Yield-on-Cost % falls into.


Lonza Group 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Lonza Group is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Lonza Group  (OTCPK:LZAGY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Lonza Group 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Lonza Group's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group (Lonza Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (OTCPK:LZAGY) » Definitions » 5-Year Yield-on-Cost %
Comparable Companies
XSWX:EMMN XSWX:ARYN XSWX:ORON XSWX:BARN XSWX:BELL XSWX:GMI XSWX:HOCN XSWX:GALD TSE:2309 TMO DHR IQV IDXX A MTD ICLR ILMN WAT SHSE:603259 LH
Traded in Other Exchanges
LZAGF:USA LONN:Mexico LONNz:UK LO3A:Germany LONNE:Switzerland LONN:Switzerland
Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Website
https://www.lonza.com
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.